ClinConnect ClinConnect Logo
Search / Trial NCT06559293

Pilot Feasibility Study of Laryngeal Ultrasound in the Paediatric Population - ECHO LARYNX

Launched by UNIVERSITY HOSPITAL, BORDEAUX · Aug 14, 2024

Trial Information

Current as of August 27, 2025

Not yet recruiting

Keywords

Transcutaneous Laryngeal Ultrasound Pediatric Population Otorhinolaryngology Ent

ClinConnect Summary

The ECHO LARYNX study is looking at a new way to examine the throat in children. Traditionally, doctors use a method called nasofibroscopy, which involves inserting a small camera through the nose to look at the larynx (the voice box). While this method is very effective, it can be uncomfortable and hard for kids to tolerate. This study will explore whether laryngeal ultrasound, a less invasive and more comfortable option, can be used instead. The goal is to see if this ultrasound technique can be practical for a larger group of children, both those with throat problems and those without.

To participate in this study, children aged 0 to 15 who are receiving treatment at the pediatric ENT unit at Bordeaux University Hospital may be eligible. However, children who are intubated (having a tube inserted to help with breathing), have serious breathing or heart issues, or whose parents or guardians do not wish to participate will not be included. If your child is selected for the study, they will undergo a laryngeal ultrasound, which is a painless procedure that uses sound waves to create images of the throat. This study is currently not yet recruiting participants, but it aims to gather valuable information that may help improve throat examinations for children in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • patients treated in the pediatric ENT unit at Bordeaux University Hospital, aged between 0 and 15 years
  • Exclusion Criteria:
  • intubated patient,
  • haemodynamic
  • respiratory instability
  • opposition to participation expressed by parents or patient

About University Hospital, Bordeaux

The University Hospital of Bordeaux is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the institution integrates cutting-edge scientific inquiry with patient care, fostering an environment that encourages collaboration among multidisciplinary teams. With a commitment to improving treatment outcomes and enhancing patient safety, the University Hospital of Bordeaux plays a pivotal role in the development of new therapies and medical technologies, contributing significantly to the global medical community.

Locations

Bordeaux, , France

Patients applied

0 patients applied

Trial Officials

Thomas SAGARDOY, MD

Principal Investigator

University Hospital, Bordeaux

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported